Incidence of symptom-driven Coronary Angiographic procedures post-drug-eluting Balloon treatment of Coronary Artery drug-eluting stent in-stent Restenosis-does it matter?
Journal of Cardiology and Cardiovascular Medicine · 2017
DOI: 10.29328/journal.jccm.1001011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiology and Cardiovascular Medicine, 2017. Verfasst von Victor Voon und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
The clinical impact of drug-eluting balloon (DEB) coronary intervention for drug-eluting in-stent restenosis (DES-ISR) is not fully known. To further evaluate this impact, we aimed to describe the incidence of symptom-driven coronary angiography (SDCA), an under-reported but potentially informative outcome metric in this cohort of patients.
Methods
We retrospectively identified all patients (n=28) who had DEB-treated DES-ISR at University Hospital Limerick in between 2013-2015 and evaluated the incidence of subsequent SDCA as the primary endpoint. Data were expressed as mean ± SD and %.
Results
Baseline demographics demonstrate a mean age 63±9 years with 61% of DEB-treated DES-ISR presenting with acute coronary syndrome. Mean number of ISR per patient and number of DEB per lesion was 1.2±0.6 lesions and 1.2±0.6 balloons, respectively. The incidence of SDCA was 54% after mean follow-up duration of 179±241 days. 67.8% of patients had follow-up data beyond 12 months. Within the first year of follow-up, the incidence of SDCA with and without target lesion revascularization (TLR) was 11% and 36% respectively. Among patients with SDCA without TLR, 30% had an acute coronary syndrome not requiring percutaneous coronary intervention.
Conclusions
A high incidence of SDCA was observed, particularly within the first 12 months after DEB-treated DES-ISR. This under-reported metric may represent a cohort at higher cardiovascular risk but requires further confirmation in larger studies.
Zitieren
APA
Voon, V., Gumani, D., Craig, C., Cahill, C., Mustafa, K., Hennessy, T., Arnous, S., & Kiernan, T. (2017). Incidence of symptom-driven Coronary Angiographic procedures post-drug-eluting Balloon treatment of Coronary Artery drug-eluting stent in-stent Restenosis-does it matter?. Journal of Cardiology and Cardiovascular Medicine. https://doi.org/10.29328/journal.jccm.1001011
Vancouver
Voon V, Gumani D, Craig C, Cahill C, Mustafa K, Hennessy T, et al. Incidence of symptom-driven Coronary Angiographic procedures post-drug-eluting Balloon treatment of Coronary Artery drug-eluting stent in-stent Restenosis-does it matter?. Journal of Cardiology and Cardiovascular Medicine. 2017. doi:10.29328/journal.jccm.1001011
BibTeX
@article{Voon2017,
author = {Voon, Victor and Gumani, Dikshaini and Craig, Calvin and Cahill, Ciara and Mustafa, Khalid and Hennessy, Terry and Arnous, Samer and Kiernan, Thomas},
title = {Incidence of symptom-driven Coronary Angiographic procedures post-drug-eluting Balloon treatment of Coronary Artery drug-eluting stent in-stent Restenosis-does it matter?},
journal = {Journal of Cardiology and Cardiovascular Medicine},
year = {2017},
doi = {10.29328/journal.jccm.1001011}
}
EUVIMED